The Board of Directors of Vijaya Diagnostic Centre met on February 13, 2026, to approve the Unaudited Financial Results for the third quarter ended December 31, 2025. Key decisions included the appointment of two new Non-Executive Independent Directors, Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola, for a five-year term. Furthermore, the Board approved the appointment of a new Chief Financial Officer (CFO), Mr. Ankit Shah, following the resignation of the previous incumbent.
Outcome of the Board Meeting on February 13, 2026
The Board of Directors of Vijaya Diagnostic Centre Limited convened on Friday, February 13, 2026, and approved several significant matters, including the financial results for the period ending December 31, 2025. The meeting addressed key personnel changes and management structure updates.
Financial Results Approval
The Board noted/approved the Unaudited Standalone and Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2025.
Key Board Approvals: Director Appointments
Based on the recommendation of the Nomination and Remuneration Committee, the Board approved two appointments:
- The appointment of Mr. Ravi Shankararamiah (DIN: 00180746) as an additional director in the capacity of Non-Executive-Independent Director for a period of five (5) years, effective February 13, 2026, subject to shareholder approval. Mr. Shankararamiah is noted as a senior and highly accomplished Senior Advocate with extensive experience in taxation and corporate law.
- The appointment of Dr. Sasikala Paruchuri Kola (DIN: 00129614) as an additional director in the capacity of Non-Executive-Independent Director for a period of five (5) years, effective February 13, 2026, subject to shareholder approval. Dr. Kola is an experienced Consultant Gynaecologist and Obstetrician.
Key Board Approvals: Executive Changes
The Board also noted the following executive transitions:
- Resignation of CFO: The resignation of Mr. S. Ramachandra Reddy from the position of Chief Financial Officer (CFO) was noted, effective February 13, 2026. Mr. Reddy will continue to serve the Company as General Manager – Finance & Accounts following organizational restructuring.
- Appointment of CFO and Key Management Personnel (KMP): The Board approved the appointment of Mr. Ankit Shah as the new Chief Financial Officer (CFO) & Key Managerial Personal, effective February 13, 2026. Mr. Shah is authorized to handle material disclosures to stock exchanges. His profile highlights extensive expertise in strategic business planning, finance, and audit.
- Other Key Appointments: The appointments of Mr. Sai Prasad as Chief Technology Officer (CTO) and Mr. Venkata Siva Rama Raju Vegesna as Chief Operating Officer (COO) were approved, both effective February 13, 2026.
Employee Stock Option Plan (ESOP) Grant
The Board approved the Grant of 1,15,000 Employee Stock Options (ESOPs) under the “VDCL Employee Stock Option Plan 2018”. These options carry a face value of ₹1/- each. The exercise price for these ESOPs is set at ₹809/- per option, calculated as the average closing price over the preceding three months, reduced by a 20% discount. Vesting is set to commence after one (1) year from the grant date, with a maximum exercise period of Ten (10) years.
Policy Revision
Finally, based on recommendations from the Audit Committee, the Board has revised the Policy for dealing in Related Party Transaction (RPT Policy), which is annexed to the filing.
Source: BSE
